window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 16, 2025

  • News
  • About Us
Contact Us

Immuno Oncology

  • Clinical Development,Oncology,Research & Development

    Williams Cancer Institute reports success with combined ablation and immunotherapy

    Study shows tumour regression with no treatment-related toxicity in head [...]

    November 10, 2025
  • Clinical Development,Drug Development,Movers & Shakers,Oncology,Pharmaceuticals and therapeutics

    Pheon therapeutics strengthens board with oncology R&D expert Dr Samuel Blackman

    Pheon Therapeutics, a clinical-stage antibody-drug conjugate (ADC) specialist, has appointed [...]

    September 23, 2025
  • Biotech,Global health,Pharmaceuticals and therapeutics,Research & Development

    MaaT Pharma reports strong Phase 3 results and EMA submission for Xervyteg

    MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotech focused on microbiome-based [...]

    September 22, 2025
  • Cell & Gene Therapy,Clinical Development,Clinical Trials,European biotech,Partnerships & Funding,Patient Centricity

    Anocca raises SEK 440M to advance TCR-T cell therapies into clinical development

    Swedish clinical-stage biotech Anocca AB has secured approximately SEK 440 [...]

    August 19, 2025
  • Oncology,Partnerships & Funding

    Adagene secures up to $25 million strategic investment from Sanofi

    Expanded partnership includes new clinical trial and third SAFEbody discovery [...]

    July 1, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Oncology,Partnerships & Funding

    eXmoor and Signadori Bio partner to advance monocyte-based cell therapy for solid tumours

    New alliance focuses on translation, process development and GMP-readiness for [...]

    July 1, 2025
  • Cell & Gene Therapy,Clinical Trials,Drug Development,Oncology,Technology and platforms

    Galapagos CAR-T therapy shows strong results in relapsed indolent NHL

    Galapagos has announced promising results from Cohort 3 of its [...]

    June 27, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development,Oncology,Precision medicine,Technology and platforms

    Galapagos taps CELLforCURE by SEQENS to manufacture CAR-T therapy in France

    CELLforCURE by SEQENS has partnered with Galapagos to manufacture GLPG5101, [...]

    June 27, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development,Oncology,Partnerships & Funding,Technology and platforms

    Mabion manufactures first batch of NovalGen’s bispecific T-cell engager for clinical trials

    Poland-based CDMO Mabion has completed the first GMP-compliant batch of [...]

    June 27, 2025
  • Clinical Trials,Drug Delivery & Formulation,Oncology,Patient Centricity,Precision medicine,Technology and platforms

    Can cryoablation plus intratumora immunotherapy rewrite the rules of cancer treatment?

    Q&A with Dr Jason Williams, founder of the Williams Cancer [...]

    June 26, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction
    Categories: Artificial Intelligence, Biotech, Clinical Development, Diagnostics, Digital Health, Drug Development, Global health, Healthcare leadership, Precision medicine, Women's Health
  • FDA approves Kura and Kyowa Kirin’s ziftomenib for relapsed or refractory AML
    Categories: Drug approval, Oncology, Pharmaceuticals and therapeutics
  • Successful treatment for ALS could deliver billions in global value
    Categories: Neurosciences, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top